← Open Payments lookup

KELLY MARTIC: Open Payments

NPI 1164068250 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,358 in 115 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $570 · 2025 $2,358

Food & beverage: $2,268Education: $90
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP26$509
GlaxoSmithKline, LLC.17$327
GENZYME CORPORATION13$282
JAZZ PHARMACEUTICALS INC.8$231
Regeneron Healthcare Solutions, Inc.9$148
HARMONY BIOSCIENCES LLC7$143
Takeda Pharmaceuticals U.S.A., Inc.4$123
Verona Pharma, Inc.5$85
Novartis Pharmaceuticals Corporation4$79
United Therapeutics Corporation3$77

Products named: DUPIXENT, NUCALA, XYWAV, TEZSPIRE, FASENRA, WAKIX, GLASSIA, XOLAIR.

Industry payments across VA — which companies pay providers there.